CTASX
Price
$37.90
Change
+$0.34 (+0.91%)
Updated
Jul 16 closing price
Net Assets
427.9M
VSGIX
Price
$78.86
Change
+$0.63 (+0.81%)
Updated
Jul 16 closing price
Net Assets
36.92B
Interact to see
Advertisement

CTASX vs VSGIX

Header iconCTASX vs VSGIX Comparison
Open Charts CTASX vs VSGIXBanner chart's image
Calamos Timpani Small Cap Growth A
Price$37.90
Change+$0.34 (+0.91%)
VolumeN/A
Net Assets427.9M
Vanguard Small Cap Growth Index I
Price$78.86
Change+$0.63 (+0.81%)
VolumeN/A
Net Assets36.92B
CTASX vs VSGIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CTASX vs. VSGIX commentary
Jul 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTASX is a Hold and VSGIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSGIX has more cash in the bank: 36.9B vs. CTASX (428M). CTASX pays higher dividends than VSGIX: CTASX (2.29) vs VSGIX (0.55). CTASX was incepted earlier than VSGIX: CTASX (12 years) vs VSGIX (25 years). CTASX (1.35) is less costly to investors than VSGIX (0.06). CTASX is a more actively managed with annual turnover of: 229.00 vs. VSGIX (21.00). CTASX has a lower initial minimum investment than VSGIX: CTASX (2500) vs VSGIX (5000000). CTASX annual gain was more profitable for investors over the last year : 14.43 vs. VSGIX (3.92). CTASX return over 5 years is better than : 43.81 vs. VSGIX (35.54).
CTASXVSGIXCTASX / VSGIX
Total Expense Ratio1.300.062,167%
Annual Report Gross Expense Ratio1.350.062,250%
Fund Existence12 years25 years-
Gain YTD4.638-0.701-662%
Front Load5%N/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets428M36.9B1%
Annual Yield % from dividends2.290.55413%
Returns for 1 year14.433.92368%
Returns for 3 years56.1337.73149%
Returns for 5 years43.8135.54123%
Returns for 10 years102.79110.2093%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARTV2.380.26
+12.26%
Artiva Biotherapeutics Inc
CEP35.241.66
+4.94%
Cantor Equity Partners Inc
CR187.431.68
+0.90%
Crane Company
VCYT25.17-1.48
-5.55%
Veracyte
PHH0.95-0.06
-5.93%
Park Ha Biological Technology Co Ltd